Elicera Therapeutics Q2 loss widens to SEK 6.3 million
Elicera Therapeutics reported a Q2 loss for the period of SEK 6.3 million.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.